ElevateBio is a company focused on creating and operating a portfolio of cell and gene therapy companies to develop, manufacture and commercialize life-transforming medicines. The company is building a facility that is intended to manufacture experimental gene and cell therapies for multiple startups, and aims to invest in those companies and help them grow. ElevateBio provides its portfolio companies with basic and translational research, process development, cGMP manufacturing, clinical development, regulatory affairs, and commercial operations.
|Employees (est.) (Mar 2020)||60||(+18%)|
ElevateBio total Funding
ElevateBio latest funding size
Time since last funding
|2 days ago|
|EDBI, MPM Capital, Redmile Group, F2 Ventures, EcoR1 Capital, Vertex Ventures, Samsara BioCapital, Surveyor Capital, UBS Oncology Impact Fund, The Invus Group, BioCapital|
ElevateBio has 119 Twitter Followers. The number of followers has increased 2.1% month over month and increased 13.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was ElevateBio founded?
ElevateBio was founded in 2017.
How many employees does ElevateBio have?
ElevateBio has 60 employees.
Who are ElevateBio competitors?
Competitors of ElevateBio include TransCure bioServices, Chrometec Capital and Start Codon.
Where is ElevateBio headquarters?
ElevateBio headquarters is located at 139 Main St Suite 500, Cambridge.
Where are ElevateBio offices?
ElevateBio has an office in Cambridge.
How many offices does ElevateBio have?
ElevateBio has 1 office.
Receive alerts for 300+ data fields across thousands of companies